Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07393529 · ClinicalTrials.gov registry record · NA

A Pilot Randomized Controlled Trial of a Social Network Intervention

A NA study, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
70
Enrollment target

NCT07393529: Recruiting NA study, sponsored by University of Rochester.

NCT07393529 is a NA study that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07393529, a NA study, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

This is a pilot randomized controlled trial to assess the feasibility, acceptability, appropriateness, and structure of the SONATA intervention. In addition, it will assess the preliminary efficacy of SONATA compared to enhanced usual care among 70 older adults with advanced cancer.

Primary Outcome

Retention rate. Percentage of patients who complete at least three SONATA sessions and week 16 post-intervention assessments

Interventions

  • BEHAVIORAL SONATA

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2026-04-10
Est. Completion 2029-03-31
Phase NA
University of Rochester

636 total trials

What NCT07393529 shows while recruiting

NCT07393529 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which SONATA is the first listed.

NCT07393529 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07393529 about?

NCT07393529 is a clinical study titled "A Pilot Randomized Controlled Trial of a Social Network Intervention". This is a pilot randomized controlled trial to assess the feasibility, acceptability, appropriateness, and structure of the SONATA intervention. In addition, it will assess the preliminary efficacy of SONATA compared to enhanced usual care among 70 older adults with advanced cancer.

What is the current status of trial NCT07393529?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-04-10. Estimated completion is 2029-03-31.

What interventions are being tested in trial NCT07393529?

The interventions under investigation include: SONATA (BEHAVIORAL).

Who is sponsoring clinical trial NCT07393529?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07393529's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07393529, the US trial registry maintained by the National Library of Medicine. NCT07393529 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.